Person

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines – VTYX

Retrieved on: 
Monday, April 8, 2024
Prior, Psoriasis, Register, Form, District court, Defendant, News, Ext, LLP, IPO, Security (finance), Inflammation, Plaque, Prospectus, Complaint, File, Pomerantz, Action Replay, Court, Person

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. (“Ventyx” or the “Company”) (NASDAQ: VTYX) and certain officers.

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. (“Ventyx” or the “Company”) (NASDAQ: VTYX) and certain officers.
  • To discuss this action, contact Danielle Peyton at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Ventyx is a clinical-stage biopharmaceutical company that develops small-molecule product candidates to address a range of inflammatory diseases.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amylyx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – AMLX

Retrieved on: 
Monday, April 8, 2024
Prior, Apoptosis, ALS, District court, Patient, AMX0035, Amyotrophy, Ext, LLP, Prescription, IBD, Complaint, Pomerantz, Action Replay, Food, Court, Evercore, Person, Pharmaceutical industry

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Amylyx Pharmaceuticals, Inc.  (“Amylyx” or the “Company”) (NASDAQ: AMLX) and certain officers.

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Amylyx Pharmaceuticals, Inc.  (“Amylyx” or the “Company”) (NASDAQ: AMLX) and certain officers.
  • To discuss this action, contact Danielle Peyton at [email protected] or 646-581-9980 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Studio City Finance Limited Announces Tender Offer for Up to US$100 Million of Its 6.000% Senior Notes due 2025

Retrieved on: 
Monday, April 8, 2024
Deutsche Bank, TEL, COVID-19, City, Attention, Person, Winchester House, Date, One Raffles Quay, Tender offer, Note, Syndicate, Tender, Cryptocurrency

MACAU, April 08, 2024 (GLOBE NEWSWIRE) -- Studio City Finance Limited (“Studio City Finance”) today announces that it has initiated a cash tender offer for up to an aggregate principal amount of US$100 million (the “Maximum Tender Amount”) of its outstanding 6.000% senior notes due 2025 (ISIN: US86389QAE26 and USG85381AE48) (the “Notes” and such tender offer, the “Tender Offer”).

Key Points: 
  • MACAU, April 08, 2024 (GLOBE NEWSWIRE) -- Studio City Finance Limited (“Studio City Finance”) today announces that it has initiated a cash tender offer for up to an aggregate principal amount of US$100 million (the “Maximum Tender Amount”) of its outstanding 6.000% senior notes due 2025 (ISIN: US86389QAE26 and USG85381AE48) (the “Notes” and such tender offer, the “Tender Offer”).
  • The Tender Offer will expire at 5:00 p.m., New York City time, on May 6, 2024, unless extended or terminated by Studio City Finance (the “Expiration Time”).
  • If the Tender Offer is fully subscribed as of the Early Tender Date, holders who validly tender Notes following the Early Tender Date will not have any of their Notes accepted for payment unless Studio City Finance increases the Maximum Tender Amount.
  • Studio City Finance has appointed Kroll Issuer Services Limited to serve as the tender and information agent for the Tender Offer.

Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Checkpoint Therapeutics, Inc. (CKPT)

Retrieved on: 
Monday, April 8, 2024
Radiation, CKPT, Patient, SAN, News, LLP, Acquisition, Checkpoint, CMO, FDA, BLA, Person, Pharmaceutical industry

SAN DIEGO, April 07, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) securities between March 10, 2021 and December 15, 2023.

Key Points: 
  • SAN DIEGO, April 07, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) securities between March 10, 2021 and December 15, 2023.
  • For more information, submit a form , email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
  • A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.
  • If you choose to take no action, you can remain an absent class member.

Intermap Drives Infrastructure Advancements in Greece and Malawi

Retrieved on: 
Monday, April 8, 2024
Professional, Intermap Technologies, Data, Face, Information technology, Intelligence, Partnership, Risk, DSM, Internet, IMP, News, 3D, Drought, Fishery, Rural development, DTM, Flood, TSX, Investment, Landslide, Sustainable development, Tourism, Water resources, Government, Earthquake, Person

DENVER, April 08, 2024 (GLOBE NEWSWIRE) -- Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“Intermap” or the “Company”), a global leader in 3D geospatial products and intelligence solutions, today announced two infrastructure projects in Greece and Malawi, providing applications that leverage recent advancements in AI/ML.

Key Points: 
  • DENVER, April 08, 2024 (GLOBE NEWSWIRE) -- Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“Intermap” or the “Company”), a global leader in 3D geospatial products and intelligence solutions, today announced two infrastructure projects in Greece and Malawi, providing applications that leverage recent advancements in AI/ML.
  • Intermap has received a contract award alongside its partner, ALVO, to provide 3D precision elevation data to the Hellenic Republic Ministry of Rural Development and Food in Greece (“Greek Ministry of Agriculture”).
  • “Intermap’s NEXTMap DSM is an excellent solution for our purpose,” said Dimitris Messinezis, Founder and CEO of ALVO in Greece.
  • “Our expertise in 3D precision geospatial data makes us a valuable partner for ALVO in delivering advanced solutions for the agriculture industry in Greece.

SHLS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Shoals Technologies Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Retrieved on: 
Monday, April 8, 2024
Defendant, Copper, Class, News, Complaint, Court, Person, Cryptocurrency

The 2Q23 10-Q disclosed that Shoals had recorded a warranty liability of $9.3 million related to the shrinkback issue.

Key Points: 
  • The 2Q23 10-Q disclosed that Shoals had recorded a warranty liability of $9.3 million related to the shrinkback issue.
  • As investors belatedly found out, Shoals had installed defective wire harnesses in at least 300 solar fields.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

NOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sunnova Energy International Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Retrieved on: 
Monday, April 8, 2024
NOVA, Risk, Complaint, Court, Person, Insurance

Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/NOVA .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/NOVA .
  • The Complaint alleges that throughout the Class Period Defendants made materially false and misleading statements regarding the Company's business, operations, and compliance policies.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

IRBT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that iRobot Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Retrieved on: 
Monday, April 8, 2024
Amazon, IRBT, Complaint, Amazon (company), IRobot, Court, Person

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against iRobot Corporation (“iRobot” or “the Company”) (NASDAQ: IRBT) and certain of its officers.

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against iRobot Corporation (“iRobot” or “the Company”) (NASDAQ: IRBT) and certain of its officers.
  • Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/IRBT .
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

Transparency Notifications from Shareholders

Retrieved on: 
Monday, April 8, 2024
GRAC, Financial services, Belfius, Disclosure, Person, FSMA, Security (finance)

(1) The total number of outstanding shares of the Company mentioned in the relevant transparency notifications amounts to 35,909,420, each share giving right to one (1) vote (being 35,909,420 voting rights in total).

Key Points: 
  • (1) The total number of outstanding shares of the Company mentioned in the relevant transparency notifications amounts to 35,909,420, each share giving right to one (1) vote (being 35,909,420 voting rights in total).
  • The notification furthermore specifies that the participation is held by Mr. C.A.C.M.
  • It follows from the notification that Belfius Bank does not own any voting securities or voting rights in the Company.
  • To access copies of the aforementioned transparency notifications, reference is made to Sequana Medical's website ( https://www.sequanamedical.com/investors/shareholder-information/ ).

NOVA 9-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Sunnova (NOVA) Investors with Substantial Losses to Contact its Attorneys Before Apr. 16th Deadline in Securities Class Action

Retrieved on: 
Sunday, April 7, 2024
NOVA, Risk, Ranking, SAN, LPO, News, Person, Primary energy, DOE

SAN FRANCISCO, April 07, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Sunnova Energy International Inc. (NYSE: NOVA) investors who suffered substantial losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, April 07, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Sunnova Energy International Inc. (NYSE: NOVA) investors who suffered substantial losses to submit your losses now .
  • This news sent the price of Sunnova shares down $2, or about 16%, on Dec. 8, 2023.
  • Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.
  • For more information, call Reed Kathrein at 844-916-0895 or email [email protected] .